CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in TNGX — Tango Therapeutics, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in TNGX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$33,512,564
+$15,967,483 QoQ
Shares Held
1,072,059
+27.8% QoQ
Ownership
0.636%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#40
of 247 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TNGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. TNGX ranks #45 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in TNGX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $33,512,564 | 1,072,059 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $17,545,081 | 838,675 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $7,451,189 | 840,992 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $5,529,652 | 658,292 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $3,079,408 | 601,447 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $750,779 | 548,014 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $1,586,495 | 513,429 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $3,751,724 | 487,237 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $3,523,780 | 410,697 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $3,013,047 | 379,477 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $3,653,753 | 369,066 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $4,136,439 | 367,357 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $398,808 | 120,123 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $489,235 | 123,857 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $897,963 | 123,857 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $460,134 | 127,109 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $574,304 | 126,778 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $184,277 | 24,311 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $265,962 | 24,311 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $314,341 | 24,311 | Shares | Sole | 2021-11-16 | |
| No filing history on record for this holder in this stock. | ||||||